This week in managed care, an analysis found the penalty for being uninsured will exceed the cost of insurance for most Americans in 2016, thousands met for the annual meeting of the American Society of Hematology, and Horizon Blue Cross Blue Shield's OMNIA plan gets good news and bad news in New Jersey.
Hello, I’m Justin Gallagher, associate publisher of The American Journal of Managed Care.
Welcome to This Week in Managed Care, from the Managed Markets News Network.
Uninsured Penalty
Starting in 2016, it looks like we will reach a tipping point when it won’t make sense to pay the tax for not being insured. According to an analysis from the Kaiser Family Foundation, for most Americans, buying the least expensive health plan on the federal marketplace exchange will cost less than the tax, which will cost $969 on average for those still without health coverage.
Rates of uninsured Americans have dropped dramatically since 2013, from just over 17 percent to 11.7 percent, but rates vary by state. To learn more about the differences across the country, read our story.
ASH Annual Meeting
This week, thousands of scientists and clinicians gathered in Orlando, Florida, for the 57th Annual Meeting of the American Society of Hematology.
As always, the FDA update was a highlight of the meeting, but this year’s news was especially exciting, with three new therapies for multiple myeloma approved just weeks before the conference. Two monoclonal antibodies—daratumumab and elotuzumab—and ixazomib, an oral protease inhibitor, were all approved this November.
Said moderator Dr Vincent Rajkumar of the Mayo Clinic, “Things have moved very well, and most of this is because we now have a plethora of new drugs to support care pathways.”
For complete coverage of ASH 2015, visit our conference page.
Enrolling in Clinical Trials
Of course, one of the challenges of bringing new therapies to market is the difficulty of finding the right patients to enroll in clinical trials.
Recently, Dr Robert Green, vice president of clinical strategy at Flatiron Health, spoke with AJMC about using electronic medical records to find patients who could benefit from taking part in a trial. Watch the video.
Tiered Network Controversy
This week, Horizon Blue Cross Blue Shield of New Jersey received both good news and bad news on its effort to get its OMNIA health plan to customers.
An appeals court denied a request to stop enrollment in the plan, and the court battle now appears headed to New Jersey’s Supreme Court. Meanwhile, 2 senators introduced four bills that would overhaul how tiered plans are created, including one that would put the brakes on OMNIA for a year.
So far, AJMC has not found another state in the country that has taken such far reaching steps to rein in tiered networks. In an exclusive, a spokesman for America’s Health Insurance Plans told AJMC: “This approach will have the harmful effect of stifling innovation and options for consumers, limiting choice, flexibility, and preventing health plans from finding additional ways to make health insurance more affordable for consumers.”
Top Healthcare News in 2015
What do YOU think is the top healthcare story of 2015? High drug prices? The ruling in King v. Burwell? Maybe the end of the Sustainable Growth Rate formula?
You can find those choices and other on our website through next week. Cast your vote, and look for our story during the holidays to learn whether your favorite is our readers’ choice for the year.
For all of us at the Managed Markets News Network, I’m Justin Gallagher. Thanks for joining us.
Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities
April 22nd 2025Researchers are calling for more targeted efforts to improve health equity after a new analysis revealed that cancer symptom documentation and burden vary across certain demographics.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More